Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Rituximab × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 35 Lymphoma, Follicular 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma 20 Lymphoma, Mantle-Cell 19 Lymphoma, B-Cell, Marginal Zone 19 Lymphoma, Non-Hodgkin 18 Lymphoma, B-Cell 13 Recurrence 11 Burkitt Lymphoma 11 Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Waldenstrom Macroglobulinemia 7 Leukemia 5 Leukemia, Hairy Cell 4 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Heart Failure 2 Dendritic Cell Sarcoma, Interdigitating 2 beta-Thalassemia 1 Thalassemia 1 Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡